BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 23272039)

  • 1. The genetic and environmental bases of complex human-disease: extending the utility of twin-studies.
    Goodin DS
    PLoS One; 2012; 7(12):e47875. PubMed ID: 23272039
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The nature of genetic and environmental susceptibility to multiple sclerosis.
    Goodin DS; Khankhanian P; Gourraud PA; Vince N
    PLoS One; 2021; 16(3):e0246157. PubMed ID: 33750973
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The nature of genetic susceptibility to multiple sclerosis: constraining the possibilities.
    Goodin DS
    BMC Neurol; 2016 Apr; 16():56. PubMed ID: 27117889
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The causal cascade to multiple sclerosis: a model for MS pathogenesis.
    Goodin DS
    PLoS One; 2009; 4(2):e4565. PubMed ID: 19242548
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The genetic basis of multiple sclerosis: a model for MS susceptibility.
    Goodin DS
    BMC Neurol; 2010 Oct; 10():101. PubMed ID: 21029420
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multiple sclerosis: Exploring the limits and implications of genetic and environmental susceptibility.
    Goodin DS; Khankhanian P; Gourraud PA; Vince N
    PLoS One; 2023; 18(6):e0285599. PubMed ID: 37379505
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The epidemiology of multiple sclerosis: insights to a causal cascade.
    Goodin DS
    Handb Clin Neurol; 2016; 138():173-206. PubMed ID: 27637959
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationship between HLA-DRB1* 11/15 genotype and susceptibility to multiple sclerosis in Iran.
    Abolfazli R; Samadzadeh S; Sabokbar T; Siroos B; Armaki SA; Aslanbeiki B; Ghelman M; Taheri T; Shakoori A
    J Neurol Sci; 2014 Oct; 345(1-2):92-6. PubMed ID: 25064442
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic and environmental factors and the distribution of multiple sclerosis in Europe.
    Handel AE; Handunnetthi L; Giovannoni G; Ebers GC; Ramagopalan SV
    Eur J Neurol; 2010 Sep; 17(9):1210-1214. PubMed ID: 20345929
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A genome scan in a single pedigree with a high prevalence of multiple sclerosis.
    Dyment DA; Cader MZ; Herrera BM; Ramagopalan SV; Orton SM; Chao M; Willer CJ; Sadovnick AD; Risch N; Ebers GC
    J Neurol Neurosurg Psychiatry; 2008 Feb; 79(2):158-62. PubMed ID: 17550985
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of HLA-DRB1 allele heterogeneity on disease risk and clinical course in a West Australian MS cohort: a high-resolution genotyping study.
    Wu JS; James I; Wei Qiu ; Castley A; Christiansen FT; Carroll WM; Mastaglia FL; Kermode AG
    Mult Scler; 2010 May; 16(5):526-32. PubMed ID: 20207784
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interaction of HLA-DRB1*1501 allele and TNF-alpha -308 G/A single nucleotide polymorphism in the susceptibility to multiple sclerosis.
    Shahbazi M; Roshandel D; Omidnyia E; Rshaidbaghan A
    Clin Immunol; 2011 Jun; 139(3):277-81. PubMed ID: 21396892
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multiple sclerosis genetics.
    Cree BA
    Handb Clin Neurol; 2014; 122():193-209. PubMed ID: 24507519
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Epidemiology of multiple sclerosis: environmental factors versus genetic factors].
    Kira J
    Nihon Rinsho; 2003 Aug; 61(8):1300-10. PubMed ID: 12962015
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of HLA-DRB1 alleles on susceptibility and outcome of a Portuguese Multiple Sclerosis population.
    Silva AM; Pereira C; Bettencourt A; Carvalho C; Couto AR; Leite MI; Marta M; Freijo M; Costa PP; Mendonça D; Monteiro L; Armas JB; Martins B
    J Neurol Sci; 2007 Jul; 258(1-2):69-74. PubMed ID: 17412364
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The association of HLA-DRB1 and HLA-DQB1 alleles with genetic susceptibility to multiple sclerosis in the Slovak population.
    Michalik J; Čierny D; Kantorová E; Kantárová D; Juraj J; Párnická Z; Kurča E; Dobrota D; Lehotský J
    Neurol Res; 2015; 37(12):1060-7. PubMed ID: 26744784
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Review of the contribution of twin studies in the search for non-genetic causes of multiple sclerosis.
    James WH
    Neuroepidemiology; 1996; 15(3):132-41. PubMed ID: 8700305
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HLA-DRB1 confers increased risk of pediatric-onset MS in children with acquired demyelination.
    Disanto G; Magalhaes S; Handel AE; Morrison KM; Sadovnick AD; Ebers GC; Banwell B; Bar-Or A;
    Neurology; 2011 Mar; 76(9):781-6. PubMed ID: 21288988
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HLA class I alleles tag HLA-DRB1*1501 haplotypes for differential risk in multiple sclerosis susceptibility.
    Chao MJ; Barnardo MC; Lincoln MR; Ramagopalan SV; Herrera BM; Dyment DA; Montpetit A; Sadovnick AD; Knight JC; Ebers GC
    Proc Natl Acad Sci U S A; 2008 Sep; 105(35):13069-74. PubMed ID: 18765817
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combination of Myelin Basic Protein Gene Polymorphisms with HLA-DRB1*1501 in Iranian Patients with Multiple Sclerosis.
    Nejati P; Attar M; Rahimian M; Fathi D; Shahbazi M
    Iran J Immunol; 2017 Sep; 14(3):231-239. PubMed ID: 28919586
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.